MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 237 filers reported holding MIRATI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,236 | +21.8% | 74,286 | +1.0% | 0.15% | +31.0% |
| Q2 2023 | $2,656 | +13.0% | 73,516 | +16.3% | 0.12% | +4.5% |
| Q1 2023 | $2,351 | +78.0% | 63,224 | +116.9% | 0.11% | +52.1% |
| Q4 2022 | $1,321 | -99.9% | 29,145 | +48.7% | 0.07% | -12.0% |
| Q3 2022 | $1,369,000 | +72.9% | 19,605 | +66.1% | 0.08% | +38.3% |
| Q2 2022 | $792,000 | -15.4% | 11,800 | +3.7% | 0.06% | -1.6% |
| Q1 2022 | $936,000 | +140.6% | 11,383 | +328.7% | 0.06% | +24.5% |
| Q4 2021 | $389,000 | -49.9% | 2,655 | -39.5% | 0.05% | -52.4% |
| Q3 2021 | $776,000 | +75.2% | 4,385 | +59.8% | 0.10% | -30.9% |
| Q2 2021 | $443,000 | +9.1% | 2,744 | +15.6% | 0.15% | +14.6% |
| Q1 2021 | $406,000 | -26.3% | 2,373 | -66.9% | 0.13% | -44.0% |
| Q1 2020 | $551,000 | – | 7,174 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |